Provided by Tiger Trade Technology Pte. Ltd.

Oncolytics Biotech Inc

0.7556
+0.01011.35%
Volume:88.73K
Turnover:67.57K
Market Cap:96.35M
PE:-2.35
High:0.7621
Open:0.7600
Low:0.7556
Close:0.7455
52wk High:1.51
52wk Low:0.7301
Shares:127.51M
Float Shares:122.97M
Volume Ratio:11.78
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3215
EPS(LYR):-0.3000
ROE:-10187.64%
ROA:-211.24%
PB:-15.62
PE(LYR):-2.52

Loading ...

Oncolytics Biotech Inc - Pelaeoreorep Combination Shows 19.5-Month Median Duration of Response in 2L Kras-Mutant Mss Mcrc

THOMSON REUTERS
·
May 04

Oncolytics Biotech Inc - Engaged With FDA on Accelerated Approval Pathway for 2L Ras-Mutant Mss Mcrc

THOMSON REUTERS
·
May 04

Analysts Have Conflicting Sentiments on These Healthcare Companies: Oncolytics Biotech (ONCY) and Agilon Health (AGL)

TIPRANKS
·
Apr 28

Oncolytics says in alignment with FDA following pelareorep Type C meeting

TIPRANKS
·
Apr 27

Oncolytics Biotech Inc - Announces Alignment With FDA on Pivotal Anal Cancer Study - SEC Filing

THOMSON REUTERS
·
Apr 27

Oncolytics aligns with FDA on pivotal pelareorep anal cancer trial design

Reuters
·
Apr 27

Top News Today: Stocks Rise Amid Hopes for Further U.S.-Iran Talks

Dow Jones
·
Apr 17

Analysts Conflicted on These Healthcare Names: Oncolytics Biotech (ONCY) and Neurocrine (NBIX)

TIPRANKS
·
Apr 07

Oncolytics Biotech signs Jefferies ATM equity sale agreement for up to $75 million

Reuters
·
Apr 07

Oncolytics Biotech Inc - to Offer and Sell Common Stock up to $75 Mln Through Jefferies - SEC Filing

THOMSON REUTERS
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali

Reuters
·
Apr 07

BUZZ-U.S. STOCKS ON THE MOVE-Tyson Foods, Atmus Filtration, Avis Budget

Reuters
·
Apr 06

BUZZ-Oncolytics rises as it schedules FDA talks on anal cancer drug

Reuters
·
Apr 06

Oncolytics schedules FDA meeting for pelareorep registrational path

TIPRANKS
·
Apr 06

Oncolytics schedules FDA Type C meeting on single-arm registrational pathway for pelareorep in anal cancer

Reuters
·
Apr 06

Oncolytics Biotech Inc - Schedules Type C FDA Meeting on April 16, 2026 for Pelareorep in Anal Cancer

THOMSON REUTERS
·
Apr 06

Oncolytics Biotech Inc - Meeting to Discuss Single-Arm Pivotal Study of Pelareorep in Second-Line and Later Scac

THOMSON REUTERS
·
Apr 06

Top News Today/Canada: Goods-Trade Deficit Widens, Surplus With U.S. Narrows

Dow Jones
·
Apr 03

Oncolytics completes domicile change to the U.S.

TIPRANKS
·
Apr 01

Oncolytics Biotech shifts headquarters to San Diego, completes Nevada domestication

Reuters
·
Apr 01